These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28324312)

  • 21. Genetic analysis in nine unrelated Italian patients affected by OTC deficiency: detection of novel mutations in the OTC gene.
    Bisanzi S; Morrone A; Donati MA; Pasquini E; Spada M; Strisciuglio P; Parenti G; Parini R; Papadia F; Zammarchi E
    Mol Genet Metab; 2002 Jun; 76(2):137-44. PubMed ID: 12083811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ornithine transcarbamylase deficiency unmasked because of gastrointestinal bleeding.
    Trivedi M; Zafar S; Spalding MJ; Jonnalagadda S
    J Clin Gastroenterol; 2001 Apr; 32(4):340-3. PubMed ID: 11276280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation.
    Tarasenko TN; Rosas OR; Singh LN; Kristaponis K; Vernon H; McGuire PJ
    PLoS One; 2015; 10(2):e0116594. PubMed ID: 25647322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of a human induced pluripotent stem cell line (SDQLCHi036-A) from a patient with ornithine transcarbamylase deficiency carrying a deletion involving 3-9 exons of OTC gene.
    Guan J; Yan B; Zhang H; Liu C; Li Y; Yang X; Li Z; Gai Z; Liu Y
    Stem Cell Res; 2021 Apr; 52():102220. PubMed ID: 33550136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemizygous deletion in the
    Wang LP; Luo HZ; Song M; Yang ZZ; Yang F; Cao YT; Chen J
    World J Clin Cases; 2022 Feb; 10(4):1417-1422. PubMed ID: 35211578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ornithine transcarbamylase deficiency: a novel splice site mutation in a family with meiotic recombination and a new useful SNP for diagnosis.
    Azevedo L; Vilarinho L; Teles EL; Amorim A
    Mol Genet Metab; 2002 May; 76(1):68-70. PubMed ID: 12175783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms underlying large genomic deletions in ornithine transcarbamylase (OTC) gene.
    Quental R; Azevedo L; Rubio V; Diogo L; Amorim A
    Clin Genet; 2009 May; 75(5):457-64. PubMed ID: 19475717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of clinical features, biochemical analysis and gene mutations in one Chinese pedigree with neonatal-onset ornithine transcarbamylase deficiency].
    Sun WH; Yang Y; Zhang YP; Li XT; Zhang M; Cao Y; Wang Y
    Zhonghua Er Ke Za Zhi; 2011 May; 49(5):356-60. PubMed ID: 21624287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiency.
    García-Pérez MA; Climent C; Briones P; Vilaseca MA; Rodés M; Rubio V
    J Inherit Metab Dis; 1997 Nov; 20(6):769-77. PubMed ID: 9427144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newborn ornithine carbamyltransferase deficiency caused by new
    Yu A; Gao D; Zeng S; Huang L; Jiang F; Feng X
    Transl Pediatr; 2023 Oct; 12(10):1887-1895. PubMed ID: 37969118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aquaporin 9 induction in human iPSC-derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency.
    Laemmle A; Poms M; Hsu B; Borsuk M; Rüfenacht V; Robinson J; Sadowski MC; Nuoffer JM; Häberle J; Willenbring H
    Hepatology; 2022 Sep; 76(3):646-659. PubMed ID: 34786702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency.
    Batshaw ML; Robinson MB; Ye X; Pabin C; Daikhin Y; Burton BK; Wilson JM; Yudkoff M
    Pediatr Res; 1999 Nov; 46(5):588-93. PubMed ID: 10541323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The R40H mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients.
    Nishiyori A; Yoshino M; Kato H; Matsuura T; Hoshide R; Matsuda I; Kuno T; Miyazaki S; Hirose S; Kuromaru R; Mori M
    Hum Genet; 1997 Feb; 99(2):171-6. PubMed ID: 9048915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice.
    Yamazaki K; Kubara K; Ishii S; Kondo K; Suzuki Y; Miyazaki T; Mitsuhashi K; Ito M; Tsukahara K
    Mol Ther Nucleic Acids; 2023 Sep; 33():210-226. PubMed ID: 37520683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.
    McCullough BA; Yudkoff M; Batshaw ML; Wilson JM; Raper SE; Tuchman M
    Am J Med Genet; 2000 Aug; 93(4):313-9. PubMed ID: 10946359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency.
    Carstens RP; Fenton WA; Rosenberg LR
    Am J Hum Genet; 1991 Jun; 48(6):1105-14. PubMed ID: 2035531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New mutation and prenatal diagnosis in ornithine transcarbamylase deficiency.
    Nussbaum RL; Boggs BA; Beaudet AL; Doyle S; Potter JL; O'Brien WE
    Am J Hum Genet; 1986 Feb; 38(2):149-58. PubMed ID: 3004207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
    Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
    Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular basis of ornithine transcarbamylase deficiency.
    Tuchman M; McCullough BA; Yudkoff M
    Eur J Pediatr; 2000 Dec; 159 Suppl 3():S196-8. PubMed ID: 11216899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.